Cargando…

CXCL4/PF4 is a predictive biomarker of cardiac differentiation potential of human induced pluripotent stem cells

Selection of human induced pluripotent stem cell (hiPSC) lines with high cardiac differentiation potential is important for regenerative therapy and drug screening. We aimed to identify biomarkers for predicting cardiac differentiation potential of hiPSC lines by comparing the gene expression profil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohashi, Fumiya, Miyagawa, Shigeru, Yasuda, Satoshi, Miura, Takumi, Kuroda, Takuya, Itoh, Masayoshi, Kawaji, Hideya, Ito, Emiko, Yoshida, Shohei, Saito, Atsuhiro, Sameshima, Tadashi, Kawai, Jun, Sawa, Yoshiki, Sato, Yoji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420577/ https://www.ncbi.nlm.nih.gov/pubmed/30874579 http://dx.doi.org/10.1038/s41598-019-40915-w

Ejemplares similares

Publisher Correction: Nanopore sequencing reveals TACC2 locus complexity and diversity of isoforms transcribed from an intronic promoter
por: Ito, Yosuke, et al.
Publicado: (2021)

Nanopore sequencing reveals TACC2 locus complexity and diversity of isoforms transcribed from an intronic promoter
por: Ito, Yosuke, et al.
Publicado: (2021)

Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction
por: Ishida, Masaru, et al.
Publicado: (2019)

2508: The role of platelet factor-4 (PF4 or CXCL4) in B cell differentiation
por: Blick, Sara, et al.
Publicado: (2018)

Single-Cell RNA-Seq Reveals LRRC75A-Expressing Cell Population Involved in VEGF Secretion of Multipotent Mesenchymal Stromal/Stem Cells Under Ischemia
por: Miura, Takumi, et al.
Publicado: (2023)

Platelet factor 4 (CXCL4/PF4) upregulates matrix metalloproteinase-2 (MMP-2) in gingival fibroblasts
por: Le, Hoa T., et al.
Publicado: (2022)

Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells
por: Yoshida, Shohei, et al.
Publicado: (2018)

P1002: PROTEOMIC SCREENING IDENTIFIES MEGAKARYOCYTE DERIVED PF4/CXCL4 AS A CRITICAL DRIVER OF MYELOFIBROSIS
por: Malara, Alessandro, et al.
Publicado: (2023)

Reduced CXCL4/PF4 expression as a driver of increased human hematopoietic stem and progenitor cell proliferation in polycythemia vera
por: Meier-Abt, Fabienne, et al.
Publicado: (2021)

PF-4var/CXCL4L1 Predicts Outcome in Stable Coronary Artery Disease Patients with Preserved Left Ventricular Function
por: De Sutter, Johan, et al.
Publicado: (2012)

Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model
por: Iseoka, Hiroko, et al.
Publicado: (2020)

Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
por: Ito, Emiko, et al.
Publicado: (2019)

Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis
por: Yoshida, Emiko, et al.
Publicado: (2017)

Highly sensitive droplet digital PCR method for detection of residual undifferentiated cells in cardiomyocytes derived from human pluripotent stem cells
por: Kuroda, Takuya, et al.
Publicado: (2015)

Restricted Presence of POU6F2 in Human Corneal Endothelial Cells Uncovered by Extension of the Promoter-level Expression Atlas
por: Yoshihara, Masahito, et al.
Publicado: (2017)

Efficient Differentiation of Mouse Induced Pluripotent Stem Cells into Alveolar Epithelium Type II with a BRD4 Inhibitor
por: Momozane, Toru, et al.
Publicado: (2019)

A simple method to estimate the in-house limit of detection for genetic mutations with low allele frequencies in whole-exome sequencing analysis by next-generation sequencing
por: Miura, Takumi, et al.
Publicado: (2021)

Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy
por: Sougawa, Nagako, et al.
Publicado: (2018)

Sustained-Release Delivery of Prostacyclin Analogue Enhances Bone Marrow-Cell Recruitment and Yields Functional Benefits for Acute Myocardial Infarction in Mice
por: Imanishi, Yukiko, et al.
Publicado: (2013)

Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia
por: Umeda, Satoshi, et al.
Publicado: (2016)

CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria
por: Wilson, Nana O., et al.
Publicado: (2011)

Exendin-4 induces extracellular-superoxide dismutase through histone H3 acetylation in human retinal endothelial cells
por: Yasuda, Hiroyuki, et al.
Publicado: (2016)

Development of a vitrification method for preserving human myoblast cell sheets for myocardial regeneration therapy
por: Ohkawara, Hirotatsu, et al.
Publicado: (2018)

PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia
por: Vayne, Caroline, et al.
Publicado: (2021)

Correction: Discovery of Molecular Markers to Discriminate Corneal Endothelial Cells in the Human Body
por: Yoshihara, Masahito, et al.
Publicado: (2015)

Discovery of Molecular Markers to Discriminate Corneal Endothelial Cells in the Human Body
por: Yoshihara, Masahito, et al.
Publicado: (2015)

High-resolution promoter map of human limbal epithelial cells cultured with keratinocyte growth factor and rho kinase inhibitor
por: Yoshihara, Masahito, et al.
Publicado: (2017)

Regulation of T cell chemotaxis by CXCL4
por: Woller, G, et al.
Publicado: (2009)

N-Glycans: Phenotypic Homology and Structural Differences between Myocardial Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Kawamura, Takuji, et al.
Publicado: (2014)

Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue
por: Iseoka, Hiroko, et al.
Publicado: (2018)

CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis
por: Gouwy, Mieke, et al.
Publicado: (2016)

Mastering pfSense: manage, secure, and monitor your on-premise and cloud network with pfSense 2.4
por: Zientara, David
Publicado: (2018)

The Role of Cytokine PF4 in the Antiviral Immune Response of Shrimp
por: Chen, Yulei, et al.
Publicado: (2016)

Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT
por: Singh, Bandana, et al.
Publicado: (2021)

CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome–negative myeloproliferative neoplasms
por: Morishita, Soji, et al.
Publicado: (2020)

Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung
por: Takamochi, Kazuya, et al.
Publicado: (2016)

Genetically Engineered Multilineage-Differentiating Stress-Enduring Cells as Cellular Vehicles against Malignant Gliomas
por: Yamasaki, Tomohiro, et al.
Publicado: (2017)

Eliminating residual iPS cells for safety in clinical application
por: Masuda, Shigeo, et al.
Publicado: (2015)

The Repressor C Protein, Pf4r, Controls Superinfection of Pseudomonas aeruginosa PAO1 by the Pf4 Filamentous Phage and Regulates Host Gene Expression
por: Ismail, Muhammad Hafiz, et al.
Publicado: (2021)

Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells
por: Takeda, Maki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nab0v3o7bjcb734amk1bbe9nc0